Find a Supplier
REQUEST A DEMO
Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
Contact Us Subscribe to Newsletter

Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors

resourcesSIRION Biotech GmbH
October 27th 2022

SIRION provides a 360° solution from early R&D up to the late preclinical AAV vector space to develop safe and efficacious AAV-based drug products. Please click on the brochure below to learn more:

Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors Download Resource

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications

FREE DOWNLOAD
Full Supplier Profile Subscribe To Supplier
×

FREE DOWNLOAD

    We would like to bring you similar content and keep you informed with updates from this supplier. By submitting this form you agree to receive these updates. We take your privacy seriously, you can unsubscribe at anytime by clicking on the unsubscribe link.

    Related Articles

    Supporting Lentiviral Vector Development
    Supporting Lentiviral Vector Development Friday 4th Nov 2022

    By  SIRION Biotech…

    SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022
    SIRION Biotech to present Viral Vector Know-How Hub… Thursday 6th Oct 2022

    By  SIRION Biotech…

    SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting
    SIRION Biotech to present insights on single cell… Friday 6th May 2022

    By  SIRION Biotech…

    SIRION Biotech achieves ISO-9001:2015 Certification
    SIRION Biotech achieves ISO-9001:2015 Certification Wednesday 6th Apr 2022

    By  SIRION Biotech…

    SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies
    SIRION teams with Centre for Genomic Regulation to… Tuesday 15th Mar 2022

    By  SIRION Biotech…

    View Articles by SIRION Biotech GmbH

    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Products & Services
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    News Releases
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    White Papers
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Videos
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
    Resources